FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith/File Photo Post navigation US FTC suspends challenge to block Amgen’s $27.8 billion deal for Horizon Therapeutics